Cargando…

Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report

Background: This study aims to investigate the activity of the remdesivir–nirmatrelvir combination against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and to report a case of Coronavirus Disease 2019 (COVID-19) cured with this combination. Methods: A Vero E6 cell-based infection ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gidari, Anna, Sabbatini, Samuele, Schiaroli, Elisabetta, Bastianelli, Sabrina, Pierucci, Sara, Busti, Chiara, Saraca, Lavinia Maria, Capogrossi, Luca, Pasticci, Maria Bruna, Francisci, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385213/ https://www.ncbi.nlm.nih.gov/pubmed/37515263 http://dx.doi.org/10.3390/v15071577

Ejemplares similares

Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2
por: Gidari, Anna, et al.
Publicado: (2022)

Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022)

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro
por: Gidari, Anna, et al.
Publicado: (2022)

Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected
por: Gidari, Anna, et al.
Publicado: (2021)

SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light
por: Gidari, Anna, et al.
Publicado: (2021)

Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria
por: Schiaroli, Elisabetta, et al.
Publicado: (2022)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
por: Gidari, Anna, et al.
Publicado: (2020)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
por: Paciaroni, Alessandro, et al.
Publicado: (2023)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione
por: Bartolini, Desirée, et al.
Publicado: (2021)

Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level
por: Torti, Carlo, et al.
Publicado: (2021)

The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication
por: Bianconi, Elisa, et al.
Publicado: (2023)

Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
por: Gidari, Anna, et al.
Publicado: (2020)

Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19
por: Patel, Dimple, et al.
Publicado: (2023)

Listeria monocytogenes Brain Abscess: Controversial Issues for the Treatment—Two Cases and Literature Review
por: Tiri, Beatrice, et al.
Publicado: (2018)

Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view
por: Ferrara, Francesco, et al.
Publicado: (2022)

Role of Nucleocapsid Protein Antigen Detection for Safe End of Isolation of SARS-CoV-2 Infected Patients with Long Persistence of Viral RNA in Respiratory Samples
por: Mencacci, Antonella, et al.
Publicado: (2021)

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
por: Baldi, Federico, et al.
Publicado: (2023)

Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir
por: Saraca, Lavinia Maria, et al.
Publicado: (2018)

Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19
por: Bianconi, Vanessa, et al.
Publicado: (2021)

Prosthetic joint infection diagnosis applying the three-level European Bone and Joint Infection Society (EBJIS) approach
por: Papalini, Chiara, et al.
Publicado: (2022)

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
por: Fiaschi, Lia, et al.
Publicado: (2022)

766. Migration Flows and Increase of Extrapulmonary Tuberculosis in a Low Prevalence Setting: A Retrospective Analysis in Two Italian Centers
por: Compagno, Mirko, et al.
Publicado: (2018)

Partial Achievement of the 90-90-90 UNAIDS Target in a Cohort of HIV Infected Patients from Central Italy
por: Schiaroli, Elisabetta, et al.
Publicado: (2020)

Electrochemical Preparation of Synergistic Nanoantimicrobials
por: Sportelli, Maria Chiara, et al.
Publicado: (2019)

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022)

The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes
por: Renga, Barbara, et al.
Publicado: (2012)

Kaposi Sarcoma in People Living with HIV: Is it Water under the Bridge?
por: Papalini, Chiara, et al.
Publicado: (2023)

The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma
por: Renga, Barbara, et al.
Publicado: (2015)

Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients
por: Piñana, José Luis, et al.
Publicado: (2023)

Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis
por: Falasca, Katia, et al.
Publicado: (2017)

Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use
por: Del Borgo, Cosmo, et al.
Publicado: (2023)

Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism
por: Pirro, Matteo, et al.
Publicado: (2017)

Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction
por: Biagioli, Michele, et al.
Publicado: (2021)

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
por: Tiseo, Giusy, et al.
Publicado: (2022)

HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes
por: Renga, Barbara, et al.
Publicado: (2012)

National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study
por: De Socio, Giuseppe Vittorio, et al.
Publicado: (2021)

The Remarkable Selectivity of Nirmatrelvir
por: Duveau, Damien Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ni9ts91s1aetaeklpr5rremj4a